Use of biopharmaceuticals such as monoclonal antibodies (mAbs) has been growing rapidly. Since biopharmaceuticals are generated from biological sources, some of the low-level host cell proteins (HCPs) could remain in the final products even after multiple purification steps. Due to their potential to affect product safety and efficacy, HCP level must be monitored and controlled in drug products according to regulatory requirements.
This study demonstrates an end to end HCP analysis workflow including the Agilent AssayMAP Bravo for automated sample preparation, 6545XT AdvanceBio LC/Q‑TOF for LC-MS/MS analysis, and software for data analysis.
To download your copy of this application note complete the form opposite.
Registrants for this application note are covered by the Eclipse Business Media Privacy Policy.
Eclipse Business Media Ltd, Regd in England, No. 06513189, Woodview, Bull Lane Industrial Estate, Sudbury, CO10 0FD, United Kingdom, T +44 (0)161 818 7434, info@sepscience.com
Eclipse Business Media Ltd needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy or contact privacy@labxmediagroup.com
Copyright © 2023. All rights reserved